ICER and the West Health Policy Center developed the 2026 “Launch Price and Access Report”, an independent analysis of drug prices and patient access for newly launched FDA-approved treatments.

This Launch Price and Access Report analyzes launch price trends over four years (2022-2025). It also includes an in-depth review of patient access to newly launched drugs using real-world pharmacy and medical claims data, and payer coverage policies.

Join us for a webinar to discuss the report findings on October 27th.

Final Documents

For questions please contact [email protected].

2026 Launch Price and Access ReportDownload
One-Pager Report SummaryDownload

Register here for Oct 27th webinar on report findings